A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma

被引：62
作者：
Adélaïde, J
Pérot, C
Gelsi-Boyer, V
Pautas, C
Murati, A
Copie-Bergman, C
Imbert, M
Chaffanet, M
Birnbaum, D
Mozziconacci, MJ [1 ]
机构：
[1] Inst J Paoli I Calmettes, Dept Mol Oncol, Inst Cancerol Marseille, F-13009 Marseille, France
[2] INSERM, U599, F-13258 Marseille, France
[3] Hop St Antoine, Lab Cytogenet, F-75571 Paris, France
[4] Inst J Paoli I Calmettes, Dept BioPathol, F-13009 Marseille, France
[5] Univ Mediterranee, Marseille, France
[6] Hop Henri Mondor, Serv Hematol Clin, F-94010 Creteil, France
[7] Hop Henri Mondor, Dept Pathol, F-94010 Creteil, France
[8] Hop Henri Mondor, Hematol Lab, F-94010 Creteil, France
来源：
LEUKEMIA | 2006年 / 20卷 / 03期
关键词：
D O I：
10.1038/sj.leu.2404104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：536 / 537
页数：2
相关论文
共 5 条
  • [1] The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene
    Bousquet, M
    Quelen, C
    De Mas, V
    Duchayne, E
    Roquefeuil, B
    Delsol, G
    Laurent, G
    Dastugue, N
    Brousset, P
    [J]. ONCOGENE, 2005, 24 (48) : 7248 - 7252
  • [2] Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case
    Heiss, S
    Erdel, M
    Gunsilius, E
    Nachbaur, D
    Tzankov, A
    [J]. HUMAN PATHOLOGY, 2005, 36 (10) : 1148 - 1151
  • [3] PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
    Murati, A
    Gelsi-Boyer, V
    Adélaïde, J
    Perot, C
    Talmant, P
    Giraudier, S
    Lodé, L
    Letessier, A
    Delaval, B
    Brunel, V
    Imbert, M
    Garand, R
    Xerri, L
    Birnbaum, D
    Mozziconacci, M
    Chaffanet, M
    [J]. LEUKEMIA, 2005, 19 (09) : 1692 - 1696
  • [4] The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2
    Reiter, A
    Walz, C
    Watmore, A
    Schoch, C
    Blau, I
    Schlegelberger, B
    Berger, U
    Telford, N
    Aruliah, S
    Yin, JA
    Vanstraelen, D
    Barker, HF
    Taylor, PC
    O'Driscoll, A
    Benedetti, F
    Rudolph, C
    Kolb, HJ
    Hochhaus, A
    Hehlmann, R
    Chase, A
    Cross, NCP
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2662 - 2667
  • [5] The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders:: Status report and immediate implications for disease classification and diagnosis
    Tefferi, A
    Gilliland, DG
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (07) : 947 - 958
1